Invasive Fungal Sinusitis

Invasive Fungal Sinusitis

Invasive Fungal Sinusitis

On this page

IFS Overview - Fungal Foes

  • Life-threatening fungal infection with invasion of sinonasal mucosa, submucosa, vasculature, and bone.
  • Primarily affects immunocompromised individuals (diabetes, neutropenia, steroid use).
  • Key Fungal Agents:
    • Aspergillus spp. (commonest worldwide)
    • Mucorales (e.g., Rhizopus, Mucor; prominent in India, esp. post-COVID)
  • Major Clinical Types:
    • Acute Invasive Fungal Sinusitis (AIFS): Rapid onset (<4 weeks), angioinvasion, necrosis.
    • Chronic Invasive Fungal Sinusitis (CIFS): Indolent (>12 weeks), may involve granulomas or be non-granulomatous.

⭐ Acute Invasive Fungal Sinusitis (AIFS) is a medical emergency requiring prompt intervention.

Fungal hyphae invading blood vessel## IFS Overview - Fungal Foes

  • Life-threatening fungal infection with invasion of sinonasal mucosa, submucosa, vasculature, and bone.
  • Primarily affects immunocompromised individuals (diabetes, neutropenia, steroid use).
  • Key Fungal Agents:
    • Aspergillus spp. (commonest worldwide)
    • Mucorales (e.g., Rhizopus, Mucor; prominent in India, esp. post-COVID)
  • Major Clinical Types:
    • Acute Invasive Fungal Sinusitis (AIFS): Rapid onset (<4 weeks), angioinvasion, necrosis.
    • Chronic Invasive Fungal Sinusitis (CIFS): Indolent (>12 weeks), may involve granulomas or be non-granulomatous.

⭐ Acute Invasive Fungal Sinusitis (AIFS) is a medical emergency requiring prompt intervention.

(image)[2931967b-4999-43ac-b7fc-7221e1105eb7]

Risk Factors & Pathogens - Susceptible Sinuses

  • Key Risk Factors: Severe immunocompromise.
    • Diabetes Mellitus (esp. DKA 📌)
    • Hematological malignancies (leukemia, lymphoma)
    • Neutropenia (ANC <500/µL)
    • Solid organ/stem cell transplant recipients
    • Prolonged high-dose corticosteroids
    • HIV/AIDS (CD4 <200 cells/µL)
  • Common Pathogens:
    • Mucorales (e.g., Rhizopus oryzae, Mucor): Broad, non-septate hyphae, right-angle branching. Angioinvasion common.

      ⭐ Mucormycosis shows a strong predilection for patients with diabetic ketoacidosis (DKA) due to the acidic, glucose-rich environment.

    • Aspergillus spp. (e.g., A. fumigatus, A. flavus): Septate hyphae, acute (45°) angle branching.
  • Sinus Predilection:
    • Maxillary (most common), Ethmoid, Sphenoid, Frontal.
    • Typically unilateral onset. Imaging of Invasive Fungal Sinusitis

Clinical Picture - Sinister Signs

  • Rapidly progressive symptoms (hours to days).
  • Severe facial pain, headache, facial numbness (CN V).
  • Periorbital edema, proptosis, ophthalmoplegia (CN III, IV, VI), diplopia.
  • Acute visual loss (CN II).
  • Nasal:
    • Black necrotic eschar on turbinates/septum.
    • Purulent, bloody, or foul discharge.
  • Palatal or gingival necrosis (black lesions).
  • Fever (often low-grade/absent).
  • Altered mental status (late, poor prognosis). image

⭐ The presence of a black necrotic eschar in the nasal cavity or on the palate is a hallmark sign highly suggestive of mucormycosis.

Diagnosis & Imaging - Unmasking Invaders

  • Nasal Endoscopy: Crucial first step. Look for pale, dusky, or black necrotic tissue (turbinates, septum), eschar formation. Insensitivity of mucosa.
  • Biopsy (Urgent & Multiple): From suspicious areas. Send for:
    • HPE (Frozen section if available): Shows hyphal invasion of tissue, vessels.

    ⭐ Histopathological examination (HPE) of a biopsy specimen demonstrating fungal hyphae invading tissue is the gold standard for diagnosing IFS.

    • Microbiology: KOH mount (rapid), fungal culture & sensitivity.
  • Imaging:
    • CECT (PNS, Orbit, Brain): Initial. Bone erosion/destruction, unilateral opacification, perisinus fat stranding. CECT showing bone erosion and sinus opacification
    • MRI with Gadolinium (PNS, Orbit, Brain): Superior for soft tissue, early intracranial/orbital spread, cavernous sinus thrombosis. T2 hypointensity (fungal elements), variable enhancement.

Treatment & Prognosis - Fungus Fightback

  • Core Strategy: Aggressive, multimodal.
    • Surgical Debridement: Prompt, wide excision of necrotic tissue.
    • Systemic Antifungals: Liposomal Amphotericin B (L-AMB); Voriconazole/Posaconazole as alternatives.
    • Control Predisposing Factors: E.g., manage diabetes, neutropenia.
  • Prognosis: Guarded. Early, aggressive intervention is key.
    • Mortality: High; depends on host immunity, disease extent.
    • Poor Prognosis: Intracranial/orbital spread, delayed Rx.

⭐ Liposomal Amphotericin B is generally preferred over conventional Amphotericin B for treating IFS due to its improved renal safety profile and better tissue penetration.

High‑Yield Points - ⚡ Biggest Takeaways

  • Affects immunocompromised patients, especially with uncontrolled diabetes or neutropenia.
  • Mucor and Aspergillus species are the most common causative fungi.
  • Classic sign: black necrotic eschar in the nasal cavity or palate.
  • Characterized by rapid angioinvasion causing tissue necrosis and orbital/intracranial spread.
  • Diagnosis: Biopsy for histopathology (hyphal invasion) is key, with CT/MRI imaging.
  • Treatment: Urgent, aggressive surgical debridement plus systemic IV Amphotericin B.
  • Carries high mortality despite prompt, aggressive management.

Practice Questions: Invasive Fungal Sinusitis

Test your understanding with these related questions

A 27-year-old intravenous drug user presents with difficulty swallowing. Examination of the oropharynx reveals white plaques along the tongue and the oral mucosa. Which of the following best describes the microscopic appearance of the microorganism responsible for this patient's illness?

1 of 5

Flashcards: Invasive Fungal Sinusitis

1/9

Fossa of Rosenmuller (yellow arrow) is visualized during the _____ pass of diagnostic nasal endoscopy.

TAP TO REVEAL ANSWER

Fossa of Rosenmuller (yellow arrow) is visualized during the _____ pass of diagnostic nasal endoscopy.

first

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial